Conference News | JOINN Chief Scientist Rao Chunming Invited to IGC 2026: In-Depth Insights into CGT Quality Control and the 2025 Chinese Pharmacopoeia Update

The 11th Immunology, Genetics and Cell Therapy Conference (IGC 2026) will be held at Crowne Plaza Beijing Chaoyang U-Town on April 16-17, 2026! With the theme of "New Policies Set Sail, Compliance Empowers, Jointly Build an Innovative Transformation Path for Advanced Therapies", this IGC conference will set up six parallel forums, including In Vivo Cells, Universal and New Indication Immune Cells, Stem Cells and Exosomes, mRNA Nucleic Acid Drugs (Non-viral Vectors), Gene Therapy (Viral Vectors), and Quality Research, Control and Regulations of Advanced Therapy Medicinal Products. In addition, it will feature exclusive closed-door senior seminars and satellite meetings, focusing on technological breakthroughs, clinical transformation, CMC challenges and commercialization in the CGT field.

Chunming Rao, Chief Scientist of Beijing JOINN Drug Inspection Research Co., Ltd., former Director of the Recombinant Drug Laboratory of the National Institutes for Food and Drug Control (NIFDC), and Second-Class Researcher, has been invited to attend this conference and deliver an authoritative keynote speech — "Research on Quality Control of CGT Products and Introduction to CGT-Related Updates in the 2025 Edition of the Pharmacopoeia", helping the industry solve quality control difficulties and grasp the new pharmacopoeia regulations!